𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker

✍ Scribed by Daniel Binder; Ann-Christin Buckendahl; Ralf-Harto Hübner; Peter Schlattmann; Bettina Temmesfeld-Wollbrück; Thomas Beinert; Norbert Suttorp


Book ID
107577380
Publisher
Springer US
Year
2010
Tongue
English
Weight
234 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES